TIOGIVA

This brand name is authorized in Austria, Finland, Ireland, United Kingdom

Active ingredients

The drug TIOGIVA contains one active pharmaceutical ingredient (API):

1 Tiotropium UNII XX112XZP0J - TIOTROPIUM BROMIDE ANHYDROUS

Tiotropium is a long-acting, specific, muscarinic receptor antagonist, in clinical medicine often called an anticholinergic. By binding to the muscarinic receptors in the bronchial smooth musculature, tiotropium inhibits the cholinergic (bronchoconstrictive) effects of acetylcholine, released from parasympathetic nerve endings. Read about Tiotropium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TIOGIVA Inhalation powder, hard capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BB04	Tiotropium bromide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 153420, 413829, 510482
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 396058, 396073, 396075